If you buy through a BGR link, we may earn an affiliate commission, helping support our expert product labs. Researchers from the University of Pittsburgh School of Medicine identified a llama ...

ExeVir’s llama-derived antibody (VHH) technology has produced the next generation COVID-19 antibody, XVR013m, which is being developed to protect millions of immunocompromised and elderly from the ...

Belgian biotech start-up ExeVir Bio says it has appointed Michael Garrett as its new chief executive (CEO), effective 1 Dec.

Llamas and alpacas have evolved antibodies that scientists 're-engineer' in the lab As Fifi the llama munches on grass on a pasture in Reading, her immune system has provided the template for a ...

That's where the llama, better known for its wool, comes in. The animals produce incredibly tiny antibodies in comparison to our own. Antibodies are weapons of the immune system and they bind to ...

Last year, Belgium’s ExeVir Bio raised 23 million euros ($27 million) to finance development of llama antibodies – and now it is ready to begin clinical development of a potential treatment ...

Llamas are important in immunology research because they produce unique antibodies that are smaller and simpler than those found in humans and fit into smaller and more recessed binding sites on the ...

In our study, we used tiny natural proteins derived from llama antibodies, called nanobodies, designed to bind specifically ...